Research & Development
Binx Health, Afaxys Group Services expand access to sexual health and wellness testing
The collaboration will enable expanded access to Binx io, a point-of-care testing platform that has been CLIA-waived and received clearance from the FDA.
November 10, 2022
Binx Health, Alabama Department of Public Health collaborate on remote STI testing
Binx Health said that COVID-19, affordability, and privacy concerns have increased the number of people choosing to participate in remote sample collection services.
October 7, 2022
GoMeyra expands information management system to include panels for monkeypox, UTIs, STIs
The GoMeyra Laboratory Information Management Systems platform now processes tests for monkeypox, UTIs, and STIs. Respiratory and toxicology tests are in the planning stages.
September 29, 2022
COVID-19 highlights need for at-home STI testing
It has been widely reported that the COVID-19 pandemic has caused declines in rates for different screening exams, and the same holds for STI screenings, according to the authors, led by Ellen Kersh, PhD, of the U.S. Centers for Disease Control and Prevention (CDC).
October 25, 2021
New world order for STD tests | Red flags on CLIA-waived products | FDA's burst of preholiday actions
Dear LabPulse Member,
May 27, 2019
STD test market grows with incidence, new tech
Not that long ago, rates of gonorrhea infection were at historically low levels, and elimination of syphilis was a reasonable goal. The diagnostics industry was able to highlight how advances in STD detection and prevention brought increased rates of detection and treatment.
May 27, 2019
Chembio Diagnostics applies for FDA CLIA waiver for HIV, syphilis test
Dr. Fauci invokes Yogi Berra to describe emerging infectious disease challenge
Thermo Fisher Scientific introduces digital PCR liquid-biopsy assays for academic, clinical research
Thermo Fisher Scientific updates Applied Biosystems genetic analyzers to comply with IVDR
Week in Review: Elizabeth Holmes sentenced; good cholesterol worse for some adults; earlier type 2 diabetes diagnosis; and more
Quest Diagnostics completes acquisition of Summa Health outreach lab services business
FDA clears 1st extragenital STD tests
The tests are designed to detect the presence of the bacteria Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) with extragenital specimens acquired via the throat and rectum. Previously, the tests were cleared only for use with urine, vaginal, and endocervical samples.
May 22, 2019
Quest sells STD tests directly to consumers
The company said the three packages are designed to meet the needs of individuals who want basic or comprehensive STD testing. It also said they are the first to be offered by a national laboratory directly for purchase by consumers.
April 17, 2019
Page 1 of 1